Top Markets
Coin of the day
China Resources Double-Crane Pharmaceutical Co.,Ltd. China Resources Double-Crane Pharmaceutical Co.,Ltd.

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062
Rang in Aktien #5805
China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its... China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its affiliated companies, operates as a prominent pharmaceutical enterprise within the People's Republic of China. The company's diverse product range includes various types of infusion solutions, available in soft bags, plastic and glass bottles, as well as inner-sealed and blend polypropylene bags. Its manufacturing capabilities extend to numerous injectable products, such as levofloxacin methylate, ambroxol hydrochloride glucose, fructose, invert sugar, hydroxyethyl starch, and sodium chloride injections, among others. Additionally, it supplies vital dialysate solutions for both peritoneal and hemodialysis. A substantial part of its portfolio is dedicated to addressing cardiovascular and cerebrovascular diseases, featuring medications like compound reserpine triamterene tablets, pitavastatin calcium tablets, telmisartan capsules, suppository capsules, banidipine hydrochloric acid sustained-release capsules, and edaravone. Furthermore, China Resources Double-Crane offers treatments for endocrinological conditions and a selection of pediatric drugs, notably including pediatric compound amino acid injections. The company's offerings also encompass nutritional supplements, such as vitamins E and C, and a variety of anti-infective pharmaceuticals. Headquartered in Beijing, the People's Republic of China, China Resources Double-Crane Pharmaceutical Co.,Ltd. is an affiliate of Beijing Pharmaceutical Group Co., Ltd.
Aktienkurs
$2.34
Marktkapitalisierung
$2.43B
Veränderung (1 Tag)
-0.37%
Veränderung (1 Jahr)
-14.62%
Land
CN
Handel China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062)

Kategorie

Kursverlauf für China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062)
Höchster Schlusskurs: $2.34 am 2026-08-01

Niedrigster Schlusskurs: $0.50 am 1997-05-01
Kursverlauf der Aktie von China Resources Double-Crane Pharmaceutical Co.,Ltd. von 1997 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -1.51%
2025 -5.80%
2024 5.00%
2023 -13.09%
2022 58.50%
2021 3.63%
2020 3.92%
2019 -4.16%
2018 -36.64%
2017 28.85%
2016 -6.72%
2015 3.00%
2014 -1.49%
2013 4.34%
2012 34.62%
2011 -44.55%
2010 31.51%
2009 14.13%
2008 -10.65%
2007 313.68%
2006 92.91%
2005 -13.37%
2004 -76.65%
2003 65.19%
2002 1.21%
2001 -2.06%
2000 108.11%
1999 1.91%
1998 10.15%
1997 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$166.18 32.04%
DE
$37.90 27.13%
JP
$222.40 27.19%
CH
$21.11 15.63%
IN